• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·ISRG
Held by 4 Gurus
Share

Intuitive Surgical, Inc. Stocks

$ 452.29Last Updated 23.10.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

$ 160.23B

$ 452.29
Key Takeaways

Risk factor

Strong trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Cathie Wood

Portfolio Weight (%)

0.2%

Change

-0.07%

Fund

ARK Investment Management LLC

Steven Cohen

Portfolio Weight (%)

0.1%

Change

-0.42%

Fund

Point72 Asset Management, L.P.

Kenneth Griffin

Portfolio Weight (%)

0.1%

Change

-0.06%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Cathie WoodARK Investment Management LLC0.2%-0.07%
Steven CohenPoint72 Asset Management, L.P.0.1%-0.42%
Kenneth GriffinCITADEL ADVISORS LLC0.1%-0.06%
Show more

Latest news

17.07.2026 15:15

Morning in New York: Pressure on the Tech Sector Persists

23.01.2026 15:28

Morning in New York: the "bulls" will face a test of strength

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of ISRG is 478 and suggests 5.74% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.10.2026 11:55

Top Stories This Morning: Musk Raised $40 Billion for SpaceX; Lula's Victory Sent Brazilian Markets Plummeting

26.10.2026 11:15

Fed Rates, Inflation, and Cloud Giants' Earnings: What Investors Can Expect This Week

25.10.2026 22:01

IPO roundup: Solidigm listing scrapped, OpenAI cuts valuation target

24.10.2026 16:01

Small caps last week: Deals for Silence and Braze, hair-loss pill success

24.10.2026 13:01

AI investors are already on the brink, a “French kiss” for the euro, and hackers at the gates

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026